Allworth Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Allworth Financial’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81K	Sell	692 -5	-0.7%	-$502	﹤0.01%	2092
2026 Q1	$64.4K	Buy	697 +17	+3%	+$1.6K	﹤0.01%	2143
2025 Q4	$53.7K	Buy	680 +17	+3%	+$1.22K	﹤0.01%	2145
2025 Q3	$48.6K	Buy	663 +11	+2%	+$699	﹤0.01%	2123
2025 Q2	$33.2K	Buy	652 +19	+3%	+$846	﹤0.01%	2199
2025 Q1	$25.6K	Hold	633	–	–	﹤0.01%	1929
2024 Q4	$29.6K	Buy	633 +3	+0.5%	+$125	﹤0.01%	1858
2024 Q3	$24.6K	Hold	630	–	–	﹤0.01%	1782
2024 Q2	$24.9K	Hold	630	–	–	﹤0.01%	1744
2024 Q1	$15.8K	Hold	630	–	–	﹤0.01%	1903
2023 Q4	$18.6K	Hold	630	–	–	﹤0.01%	1692
2023 Q3	$19.9K	Hold	630	–	–	﹤0.01%	1516
2023 Q2	$16.3K	Hold	630	–	–	﹤0.01%	1666
2023 Q1	$15.1K	Hold	630	–	–	﹤0.01%	1615
2022 Q4	$12.3K	Hold	630	–	–	﹤0.01%	1624
2022 Q3	$13K	Hold	630	–	–	﹤0.01%	1494
2022 Q2	$12K	Hold	630	–	–	﹤0.01%	1499
2022 Q1	$14K	Hold	630	–	–	﹤0.01%	1377
2021 Q4	$10K	Buy	+630	New	+$9.8K	﹤0.01%	1381

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's MIRM Position: Q2 2026 in Review

Allworth Financial reduced its Mirum Pharmaceuticals (MIRM) stake by 0.72% in Q2 2026, selling an estimated $502 and leaving 692 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Allworth Financial first reported a position in MIRM in Q4 2021 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Allworth Financial held 692 shares of Mirum Pharmaceuticals worth $81K as of Q2 2026.
Allworth Financial sold 5 Mirum Pharmaceuticals shares in Q2 2026, an estimated $502.
Mirum Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2092 holding.
Allworth Financial first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.